CNTX - Context Therapeutics Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Context Therapeutics Inc. Common Stock
IPO Date: October 19, 2021
Sector: Healthcare
Industry: Biotechnology
Market Cap: $33.82M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.09 | 5.22%
Avg Daily Range (30 D): $0.02 | 4.22%
Avg Daily Range (90 D): $0.06 | 5.23%
Institutional Daily Volume
Avg Daily Volume: .79M
Avg Daily Volume (30 D): 1.69M
Avg Daily Volume (90 D): 1.93M
Trade Size
Avg Trade Size (Sh.): 270
Avg Trade Size (Sh.) (30 D): 278
Avg Trade Size (Sh.) (90 D): 268
Institutional Trades
Total Institutional Trades: 39
Avg Institutional Trade: $1.51M
Avg Institutional Trade (30 D): $.99M
Avg Institutional Trade (90 D): $1.41M
Avg Institutional Trade Volume: 1.18M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.35M
Avg Closing Trade (30 D): $4.59M
Avg Closing Trade (90 D): $4.59M
Avg Closing Volume: 1.91M
 
News
Oct 28, 2025 @ 12:00 PM
Step Pharma announces the appointment of Dr Karen ...
Source: Andrew Parker
Jan 14, 2025 @ 9:58 PM
Context Therapeutics Announces First Patient Dosed...
Source: Context Therapeutics Inc.
Dec 26, 2024 @ 4:26 PM
Oncology in Focus: How Emerging Therapies Are Resh...
Source: Prnewswire
Dec 20, 2024 @ 8:45 PM
Top 10 Small-Cap Stocks to Watch in 2025
Source: Professor Ari Zoldan
Jun 12, 2024 @ 1:40 PM
Is CareCloud (CCLD) Stock Outpacing Its Medical Pe...
Source: Zacks Equity Research
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.48 $-.15 $-.09
Diluted EPS $-.48 $-.15 $-.09
Revenue
Gross Profit
Net Income / Loss $-45.96M $-14.56M $-8.68M
Operating Income / Loss $-48.73M $-14.97M $-9.34M
Cost of Revenue
Net Cash Flow $-17.52M $M $M
PE Ratio